Previous 10 | Next 10 |
Image source: The Motley Fool. Inari Medical, Inc. (NASDAQ: NARI) Q2 2022 Earnings Call Aug 03, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Inari Medical, Inc. (NARI) Q2 2022 Earnings Call Transcript
Inari Medical ( NASDAQ: NARI ) stock fell ~6% post market after the company reported a net loss of -10.19M in Q2, compared to a net income of $4.07M in the prior year period. Inari said in a separate release that COO Drew Hykes will replace Bill Hoffm...
Inari Medical ( NASDAQ: NARI ) has announced leadership succession plan, with COO Drew Hykes replacing Bill Hoffman as the new CEO, effective January 1, 2023. Mr. Hykes joined the medical device company in 2017 as Chief Commercial Officer and has served as its COO since 20...
Inari Medical press release ( NASDAQ: NARI ): Q2 GAAP EPS of -$0.19 beats by $0.04 . Revenue of $92.7M (+46.1% Y/Y) beats by $4.9M . Shares -6% . For the full year 2022, we are reaffirming our revenue guidance range of $360 million to $370 million ...
Inari Medical ( NASDAQ: NARI ) said Wednesday its COO Drew Hykes will succeed Bill Hoffman as CEO, effective Jan. 1, 2023. Hykes will join NARI's board, while Hoffman will remain on the board. For further details see: Inari Medical operating chief Hykes to take o...
IRVINE, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that Chief Operating Officer Drew Hyke...
IRVINE, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its second quarte...
Inari Medical has curled up since May, with the share catching a bid and strengthening against key benchmarks. It has exposure to key alternative premia currently driving equity markets in FY22. Whilst its bottom-line fundamentals are lumpy, technical studies are supportive of fur...
IRVINE, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its second quarte...
Medical device company Inari Medical (NASDAQ:NARI) is trading higher on Tuesday after Piper Sandler initiated its coverage with an Overweight recommendation citing multiple growth drivers for a favorable set-up. The analysts led by Adam C. Maeder point out that the maker of the ClotTriever me...
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its second quarter 2024...
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm Before July 12, 2024 Deadline San Francisco, California--(Newsfile Corp. - June 26, 2024) - Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses no...
2024-06-01 18:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...